Pennant Group's Analyst Ratings and Performance in the Last Three Months

Summary

Over the past three months, four analysts have rated Pennant Group (PNTG), reflecting a mix of bullish and bearish sentiments. The 12-month average target price is $34.00, with a high of $38.00 and a low of $28.00. Analysts have updated their recommendations based on market conditions, with ratings ranging from ‘outperform’ to ‘underperform.’ Pennant Group has shown significant revenue growth at 33.73% and a net profit margin of 3.71%, although its return on equity (ROE) at 2.61% is below the industry average. The company’s debt to equity ratio is 1.1, indicating sound financial management.Benzinga

Impact Analysis

The event is classified at the company level, specifically focusing on Pennant Group’s performance metrics and analyst ratings. Analyst recommendations range from ‘hold’ to ‘outperform,’ showing mixed investor sentiment. The average target price of $34.00 suggests moderate upside potential; however, the low ROE could be a concern for investors seeking high returns.Benzinga+ 2 First-order effects include potential stock price fluctuations based on analyst ratings and market perceptions of growth potential. Second-order effects might involve investor behavior shifts, potentially impacting the healthcare sector’s attractiveness. Investment opportunities may arise in related healthcare companies with stronger growth metrics or higher ROE compared to Pennant Group.Market Beat+ 2